Bruce Joseph Shook - 26 May 2022 Form 4 Insider Report for Neuronetics, Inc. (STIM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
31 May 2022, 16:28:05 UTC
Prior SEC filing
16 Nov 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ W. Andrew Macan as Attorney-in-Fact

Key filing fact

Bruce Joseph Shook filed Form 4 for Neuronetics, Inc. (STIM) on 31 May 2022.

Key facts

  • This page summarizes Bruce Joseph Shook's Form 4 filing for Neuronetics, Inc. (STIM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 31 May 2022, 16:28.

Change

  • Previous filing in this sequence was filed on 16 Nov 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STIM transaction

Common Stock

Award

Transaction value
Shares
+38,910
Change %
+130%
Price
Shares after
68,847
Date
26 May 2022
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted stock unit ("RSU") award that vests on the earlier of (a) May 26, 2023, and (b) the Company's next annual meeting of stockholders, in each case subject to continuous service of the Reporting Person through such date.

Footnote F2

Each RSU represents a contingent right to receive one share of the Issuer's common stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .